Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma.

We performed a comprehensive genome-wide miRNA expression profiling of extranodal nasal-type natural killer/T-cell lymphoma (NKTL) using formalin-fixed paraffin-embedded tissue (n = 30) and NK cell lines (n = 6) compared with normal NK cells, with the objective of understanding the pathogenetic role of miRNA deregulation in NKTL. Compared with normal NK cells, differentially expressed miRNAs in NKTL are predominantly down-regulated. Re-expression of down-regulated miRNAs, such as miR-101, miR-26a, miR26b, miR-28-5, and miR-363, reduced the growth of the NK cell line and modulated the expression of their predicted target genes, suggesting the potential functional role of the deregulated miRNAs in the oncogenesis of NKTL. Taken together, the predicted targets whose expression is inversely correlated with the expression of deregulated miRNA in NKTL are significantly enriched for genes involved in cell cycle-related, p53, and MAPK signaling pathways. We also performed immunohistochemical validation for selected target proteins and found overexpression of MUM1, BLIMP1, and STMN1 in NKTL, and notably, a corresponding increase in MYC expression. Because MYC is known to cause repression of miRNA expression, it is possible that MYC activation in NKTL may contribute to the suppression of the miRNAs regulating MUM1, BLIMP1, and STMN1.

[1]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Gaulard,et al.  Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. , 2010, Blood.

[3]  L. Leoncini,et al.  Role of EBV in microRNA dysregulation in Burkitt lymphoma. , 2009, Seminars in cancer biology.

[4]  Hiroyuki Tagawa,et al.  Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. , 2009, Blood.

[5]  M. Lutherborrow,et al.  The clinicopathological relevance of microRNA in normal and malignant haematopoiesis , 2009, Pathology.

[6]  T. Greiner,et al.  Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro , 2011, Leukemia.

[7]  Thomas D. Schmittgen,et al.  Increased expression of microRNA‐155 in Epstein‐Barr virus transformed lymphoblastoid cell lines , 2006, Genes, chromosomes & cancer.

[8]  S. Nutt,et al.  Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance , 2006, Nature Immunology.

[9]  D. Bartel,et al.  MicroRNA-Directed Cleavage of HOXB8 mRNA , 2004, Science.

[10]  R. deLeeuw,et al.  Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies , 2009, Leukemia.

[11]  Zhi-xiang Shen,et al.  PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor. , 2008, Blood.

[12]  Thomas Tuschl,et al.  miRNAs in human cancer , 2011, The Journal of pathology.

[13]  F. Slack,et al.  MicroRNAs as potential cancer therapeutics , 2008, Oncogene.

[14]  D. Heo,et al.  MicroRNA-146a Downregulates NFκB Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell Lymphoma , 2011, Clinical Cancer Research.

[15]  Kazuhiko Hayashi,et al.  Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. , 2007, RNA.

[16]  B. Klein,et al.  Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma , 1997, Nature Genetics.

[17]  N. Rajewsky,et al.  A pancreatic islet-specific microRNA regulates insulin secretion , 2004, Nature.

[18]  Juan F. García,et al.  Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies. , 2003, Haematologica.

[19]  Karen Dybkær,et al.  Genomic Analyses Reveal Global Functional Alterations That Promote Tumor Growth and Novel Tumor Suppressor Genes in Natural Killer-Cell Malignancies , 2008 .

[20]  H. Drexler,et al.  Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma. , 2003, Leukemia research.

[21]  Burton B. Yang,et al.  MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression , 2007, Proceedings of the National Academy of Sciences.

[22]  D. Brown,et al.  The promise of microRNA replacement therapy. , 2010, Cancer research.

[23]  M. Salto‐Tellez,et al.  Activated oncogenic pathways and therapeutic targets in extranodal nasal‐type NK/T cell lymphoma revealed by gene expression profiling , 2011, The Journal of pathology.

[24]  F. Slack,et al.  Epstein-Barr virus-mediated dysregulation of human microRNA expression , 2008, Cell cycle.

[25]  S. Carotta,et al.  A role for Blimp1 in the transcriptional network controlling natural killer cell maturation. , 2011, Blood.

[26]  K. Calame,et al.  Transcriptional repressor Blimp-1 regulates T cell homeostasis and function , 2006, Nature Immunology.

[27]  Tsung-Cheng Chang,et al.  Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.

[28]  E. Izaurralde,et al.  Gene silencing by microRNAs: contributions of translational repression and mRNA decay , 2011, Nature Reviews Genetics.

[29]  Todd Wylie,et al.  Next-generation sequencing identifies the natural killer cell microRNA transcriptome. , 2010, Genome research.

[30]  Y. Matsuo,et al.  p53 alterations in human leukemia–lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization? , 2000, Leukemia.

[31]  J. Cigudosa,et al.  Mantle cell lymphoma: transcriptional regulation by microRNAs , 2010, Leukemia.

[32]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[33]  M. Lacey,et al.  MicroRNA-155 Is an Epstein-Barr Virus-Induced Gene That Modulates Epstein-Barr Virus-Regulated Gene Expression Pathways , 2008, Journal of Virology.

[34]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.